These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14064952)

  • 1. THE BROADENING OF ANTIBODY SPECTRA FOLLOWING MULTIPLE EXPOSURES TO INFLUENZA VIRUSES.
    HENLE W; LIEF FS
    Am Rev Respir Dis; 1963 Sep; 88():SUPPL 379-86. PubMed ID: 14064952
    [No Abstract]   [Full Text] [Related]  

  • 2. [EVOLUTION OF THE ANTIBODY CURVE IN ANIMALS EXPERIMENTALLY INOCULATED WITH INFLUENZA VIRUS AEQUI/URUGUAY/540/1963].
    SOMMAMOREIRA RE; TOSI HC; VALLONE EF; CANTO RM
    An Fac Med Univ Repub Montev Urug; 1964; 49():436-9. PubMed ID: 14290782
    [No Abstract]   [Full Text] [Related]  

  • 3. IMMUNOLOGIC STUDIES OF PURIFIED VIRAL HEMAGGLUTININ.
    TONG MJ; FONG J
    J Immunol; 1964 Jul; 93():35-44. PubMed ID: 14214387
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification and stabilization of influenza virus antigens for use in hemagglutination-inhibition or complement fixation antibody titrations.
    LYTLE RI; WOLLRIDGE RL
    J Lab Clin Med; 1953 Feb; 41(2):290-5. PubMed ID: 13035262
    [No Abstract]   [Full Text] [Related]  

  • 5. COFACTOR AND SPECIFIC ANTIBODIES AGAINST INFLUENZA VIRUSES. X. FORMATION OF 19S AND 7S TYPE INFLUENZA ANTIBODIES IN YOUNG AND ADULT RABBITS AND IN ROOSTERS; THE ROLE OF ANTIBODY COFACTOR.
    STYK B; HANA L
    Acta Virol; 1965 May; 9():200-9. PubMed ID: 14328218
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES OF PARAINFLUENZA VIRUSES. 3. ANTIBODY RESPONSES OF DIFFERENT ANIMAL SPECIES AFTER IMMUNIZATION.
    HSIUNG GD; CHANG PW; CUADRADO RR; ISACSON P
    J Immunol; 1965 Jan; 94():67-73. PubMed ID: 14256977
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunizing effect of different cleavage products from influenza viruses].
    Lange FC
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):390-1. PubMed ID: 5523686
    [No Abstract]   [Full Text] [Related]  

  • 9. THE LABORATORY DIAGNOSIS OF INFLUENZA.
    FLEWETT TH
    Postgrad Med J; 1963 Oct; 39(456):586-90. PubMed ID: 14054631
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antigenicity of various influenza vaccines in man].
    Kuwert E; Höhner PG; Bertrams J; Schriever O
    Dtsch Med Wochenschr; 1971 May; 96(22):938-45. PubMed ID: 4325348
    [No Abstract]   [Full Text] [Related]  

  • 11. The character of interactions of antibodies and inhibitors with influenza virus.
    Kosyakov PN; Rovnova ZI
    Acta Virol; 1969 May; 13(3):179-86. PubMed ID: 4389105
    [No Abstract]   [Full Text] [Related]  

  • 12. [FIELD TRIALS OF LIVE ATTENUATED ASIAN INFLUENZA VIRUS VACCINE (OKUNO VACCINE)].
    GOTOE H
    Sapporo Igaku Zasshi; 1963 Sep; 24():211-5. PubMed ID: 14192251
    [No Abstract]   [Full Text] [Related]  

  • 13. VIRUS STUDIES WITH GERMFREE MICE. II. COMPARATIVE RESPONSES OF GERMFREE MICE TO VIRUS INFECTION.
    TENNANT RW; PARKER JC; WARD TG
    J Natl Cancer Inst; 1965 Mar; 34():381-7. PubMed ID: 14342586
    [No Abstract]   [Full Text] [Related]  

  • 14. THE ISOLATION AND CHARACTERIZATION OF A NEW INFLUENZA TYPE B VIRUS ON TAIWAN. RES REP MR005.09-1201.4.7.
    GREEN IJ; HUNG SC; YU PS; LEE CW; PEREIRA HG
    Rep U S Nav Med Res Lab; 1963 Apr; 13():1-7. PubMed ID: 24547136
    [No Abstract]   [Full Text] [Related]  

  • 15. [The antibody level against influenza viruses in man during the course of immunization with TAB vaccines].
    GERTH HJ; WUNDT W
    Z Immun exp ther; 1962 Dec; 124():370-81. PubMed ID: 13947383
    [No Abstract]   [Full Text] [Related]  

  • 16. [COMPARATIVE STUDY OF THE DEVELOPMENT OF ANTIBODIES IN THE COURSE OF 2 INFLUENZA EPIDEMICS IN THE TOULON REGION].
    DELPY J; MOLLARET L
    Ann Inst Pasteur (Paris); 1963 Sep; 105():486-505. PubMed ID: 14088228
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of neutralizing, haemagglutination-inhibiting and strain-specific complement-fixing antibodies in guinea pigs given inactivated influenza vaccine.
    Závadová H; Vonka V
    Acta Virol; 1968 Mar; 12(2):151-6. PubMed ID: 4384403
    [No Abstract]   [Full Text] [Related]  

  • 18. PARTIAL IMMUNOLOGICAL UNRESPONSIVENESS TO VIRUS ANTIGENS IN GUINEA-PIGS.
    SCHWARTZ J; KLETTER J; KLOPSTOCK A
    Int Arch Allergy Appl Immunol; 1964; 25():83-8. PubMed ID: 14235475
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON THE EPIDEMIOLOGICAL AND VIROLOGICAL CHARACTERICS OF INFLUENZA PRESENT IN TASHKENT IN 1961].
    ILINA Ts; MEVZOS LM
    Med Zh Uzb; 1963 Dec; 12():49-53. PubMed ID: 14163194
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.
    Závadová H; Adam E; Vonka V; Domorázková E; Kratochvílová M; Burian V; Davenport FM
    Arch Gesamte Virusforsch; 1972; 36(1):53-61. PubMed ID: 5062439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.